[ Englisch] Understanding Disease Burden Among MPNs

Published on

Topics include: Understanding

Dr. Ruben Mesa describes the spectrum of possible risks for patients with myeloproliferative neoplasms, particularly polycythemia vera (PV) and essential thrombocythemia (ET). Mesa also talks about other potential contributing factors like micro-vacsular symptoms that could interfere with blood flow. Dr. Cortes describes why some symptoms are tough to categorize, as some may be directly related to cellular changes or perhaps, everyday life stresses. 

View more programs featuring and

Produced in association with

Related Programs

Defining the MPN Blast Phase

Mayo Clinic expert, Dr. Ruben Mesa, defines the “MPN blast phase,” what’s normal and why these cells are closely monitored.

Published:

Understanding the Role of a Physician Assistant (PA)

Lindsey Lyle, a physician assistant at MD Anderson Cancer Center, helps us understand the role of a physician assistant and how a PA can assist in helping to guide treatment options for patients.

Published:

Myeloproliferative Neoplasms (MPNs): What Are the Demographics?

Are there any similarities among patients with MPNs? Dr. Ruben Mesa walks us through some of the demographics for myelofibrosis neoplasms while addressing various symptoms and stages of the disease.

Published:

Advertisement
tritt unserer Gemeinschaft bei Registrieren Sie sich für Veranstaltungen Lesen Sie unseren neuesten Blog
Advertisement

Page last updated on March 18, 2014